Original Research
Copyright ©The Author(s) 1997.
World J Gastroenterol. Sep 15, 1997; 3(3): 156-159
Published online Sep 15, 1997. doi: 10.3748/wjg.v3.i3.156
Figure 1
Figure 1 Heterozygosity loss of deleted in colorectal cancer (DCC) gene (M2) of gastric cancer. N: Normal tissue DNA; T: Tumor tissue DNA; 1: Heterozygote; 2-4: loss of heterozygosity (LOH).
Figure 2
Figure 2 Heterozygosity loss of deleted in colorectal cancer (DCC) gene (M3) of gastric cancer. N: Normal tissue DNA; T: Tumor tissue DNA; 1: Heterozygote; 4: Homozygote; 2 and 3: loss of heterozygosity (LOH).
Figure 3
Figure 3 Heterozygosity loss of deleted in colorectal cancer (DCC) gene (VNTR) of gastric cancer. N: Normal tissue; T: Tumor tissue DNA; 1 and 3: Heterozygote; 2 and 4: loss of heterozygosity (LOH).
Figure 4
Figure 4 Loss of deleted in colorectal cancer (DCC) gene expression of gastric cancer. N: Normal tissue T: Tumor tissue; M: Marker of molecular weight, PBR 322/Hae III; 1 and 3: Normal expression; 2: loss of heterozygosity (LOH).